NuvaRing, the Risk of Blood Clots, and You
Earlier this year, a British Medical Journal published a study in which health researchers reported a significant correlation between the use of a NuvaRing, a widely prescribed female contraceptive product, and an elevated risk of blood clots. Their investigation determined that NuvaRing and similarly designed vaginal rings raised the risk that a patient would develop blood clots by as much as 90 percent.
While this figure is higher than a previous Food and Drug Administration (FDA) announcement of a 56 percent higher blood clot rate, the trend is consistent: the risks associated with NuvaRing are meaningful. Attesting to this fact, more than a thousand women have reported a vaginal ring adverse health event with the FDA and a similar number have filed a lawsuit against the manufacturer of this health product.
Do you need advice about whether you have a viable NuvaRing product liability claim? The attorneys at the law firm of Fears Nachawati can help you answer this important question. With years of experience helping medical product liability clients like you, we’re prepared to give you the advice you need. For your free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!